Midjourney built a body scanner and called it a spa.

Midjourney, the company that taught a generation of people to make convincing pictures of things that never happened, just shipped a machine for making pictures of things that are absolutely happening, inside your body, right now. On June 18 it launched a full-body ultrasonic scanner: half a million transducers, no radiation, a ring you are lowered through while sound maps your anatomy, with a stated goal of a complete scan in sixty seconds.

It is a genuinely cool object. It is also the clearest demonstration this year of what actually decides who wins in healthcare AI, and it is not the thing anyone is pointing at.

Start with what they refuse to call it. Midjourney is not opening clinics, it is opening spas. The output is a "body-composition map," never a diagnosis. Patients do not get scanned, they "bathe in golden light." Every one of those word choices is load-bearing. The moment the device produces a diagnosis it becomes a medical instrument, a medical instrument needs FDA clearance, and clearance takes years Midjourney would rather not spend. So they built a scanner and then built a careful story in which it is not one. What they are actually selling is the regulatory category they chose to stand in, and the hardware mostly gives them something to point at while they stand there.

This is not a one-off, and that is what makes it worth sitting with. The same month Midjourney did this from the consumer-wellness side, another company ran the mirror image from the clinical side. Doctronic is pushing autonomous prescription renewals through a Utah regulatory waiver, a state program that suspends the usual rules for companies willing to accept state oversight instead of federal. One firm redefined the product so the regulator would not apply. The other found a regulator willing to step aside. Different doors, same room: in healthcare AI in 2026, the thing you are really shipping is a regulatory category, and the winners are the ones who pick the category that lets them ship at all.

I have watched this from inside. The hardest part of putting any kind of automated decision into a care setting was never the technology, it was the question of what the thing is allowed to be called and who is on the hook when it is wrong. The team that figures out the category arbitrage beats the team with the better model every time, because a better model that cannot legally ship loses to a worse one that can. It is the same lesson I keep reaching from different directions: the durable position in healthcare AI is the governance and the procurement and the permission, not the inference. Midjourney just gave the cleanest version of it yet, because of the detail that makes the whole thing almost funny.

The AI company shipped a device with no AI in it.

The current scanner has no machine learning in its imaging pipeline at all. It takes about twenty minutes, not sixty seconds. Roughly a dozen people have been through the prototype. It has no clearance to diagnose anything, and the company is upfront that the AI and the clearance come later, with a third-generation device years out. So strip it down: a famous AI brand, a regulatory category chosen specifically to avoid having to prove anything, and a piece of hardware that does not yet do what the brand implies. The famous name stands in for a model that does not exist yet, and the spa label buys the years until it does. The model, the supposed point of an AI company, is the one part not in the room.

That is not a criticism. It is, honestly, good operating. The play is the oldest one in platforms: get the install base while the rules are loose, accumulate the scans nobody else has, and let capability and clearance catch up to a position you already hold. A billion scans a month by the early 2030s, the stated ambition, is a dataset no incumbent imaging company will ever assemble through the front door of the clinic, precisely because the clinic is regulated and the spa is not. You do not need the AI to be good on day one. You need to be the one holding the data and the storefront on the day the AI gets good.

But every regulatory-category dodge is a clock. "Body-composition map" works right up until a spa scan misses something a doctor would have caught, or catches something that sends a healthy person into a spiral of unnecessary follow-ups, and a court or a regulator decides that a machine mapping your organs is practicing medicine no matter what the sign on the door says. The Utah waiver works right up until the first lawsuit tests what "supervised" means. Redefining the product does not remove the medical question. It defers it, and bets that real capability and real clearance arrive before the deferral runs out. That is the actual race, and it is not a race between scanners. It is a race between how fast the technology becomes trustworthy and how fast the regulator notices that the spa is a clinic with better lighting.

So watch the category, not the device. The body scanner is impressive and the golden light is good theater, but the thing being sold in that room is not imaging. It is permission, rented cheaply while it is still cheap. Whoever understands that is building healthcare's next platform. Whoever is still arguing about whose model is better is going to lose to a spa.

—TJ